Avanti Research Products

Avanti Polar Lipids is a premier supplier of high-purity lipids and lipid-based technologies for the global life sciences industry. Founded in 1967, the company specializes in the synthesis and purification of phospholipids, sphingolipids, and specialized lipid conjugates. Their products are critical components in the development of lipid nanoparticles (LNPs) for mRNA vaccines, gene therapies, and targeted drug delivery systems. In addition to its extensive catalog of research-grade products, Avanti provides contract development and manufacturing services (CDMO) under cGMP standards. The company gained significant prominence for its role in supplying essential lipids for the Pfizer-BioNTech COVID-19 vaccine. In 2020, Avanti was acquired by Croda International to bolster its Life Sciences division and expand its drug delivery capabilities.